NeuroBlu Reviews

Aetion Evidence Platform®, provides real-world evidence to life sciences companies, payers, as well as at-risk providers. We help you answer the most important questions in health care: What works best for whom and when? Better answers mean better decisions. Aetion is a trusted partner to most of the top 20 biopharma companies, leading payers, as well as the FDA. This helps inform the industry's most important decisions. Our transparent analyses help guide product development, commercialization, payment innovation, and the transition to modern health care. The Aetion Evidence Platform transforms the application of real-world data from descriptive analytics to causal conclusions. It delivers quick results, with answers in days or weeks. This is critical for improving financial and clinical outcomes. Transform your best information into useful insights that you can use immediately.

Healthcare organizations (including hospitals, clinics, and health plans) can now connect with app developers and data partners to create new FHIR-based digital services. Ensure safer and more efficient transitions across the continuum between in-patient and outpatient care. At-risk patients can be provided with targeted prevention and wellness guidance. To effectively manage chronic conditions, encourage collaboration between healthcare providers, patients, and physicians. Improve management of chronic conditions. Provide patient-centric digital services. Reduce risks during care transitions. Secure, manage, and scale APIs using an enterprise-grade platform, which is FHIR-server neutral. Access healthcare data from FHIR-ready partners, whether they are internal, external, open-source, or both. You can quickly launch digital services such as new mobile apps to fulfill the promise of patient-centric care and data interoperability.